Rivaroxaban in patients with mechanical heart valves: A pilot study

Patients with mechanical heart valves are still not eligible for treatment with direct oral anticoagulants (DOAC). We aimed to conduct a proof-of-principle study investigating the anti-Xa inhibitor rivaroxaban as antithrombotic treatment in patients with recent mechanical aortic valve replacement.
Source: Thrombosis Research - Category: Hematology Authors: Tags: Full Length Article Source Type: research